医学
美波利祖马布
鼻息肉
慢性鼻-鼻窦炎
皮肤病科
内科学
鼻窦炎
胃肠病学
外科
嗜酸性粒细胞
哮喘
作者
Martin Desrosiers,Zuzana Diamant,Paolo Castelnuovo,Peter W. Hellings,Joseph K. Han,Anju T. Peters,Jared Silver,Steven G. Smith,Abigail Fuller,Ana R. Sousa,Robert Chan,Philippe Gevaert,the SYNAPSE study investigators
摘要
Fifty-two weeks of mepolizumab treatment is associated with sustained clinical benefits up to 24 weeks after discontinuation in patients with severe CRSwNP, which should be considered by physicians when making treatment decisions.
科研通智能强力驱动
Strongly Powered by AbleSci AI